Three Sisters Claim In Utero Exposure to DES Led to Cervical Malformations and Infertility
December 3, 2002
DOCUMENTS
- Complaint
- Notice of Removal
WASHINGTON, D.C.-Three sisters have filed a products liability lawsuit against the manufacturer of Diethylstilbestrol (DES) claiming that they have sustained injuries including cervical malformations and infertility as a result of embryonic exposure to the drug. Roing, et al., v. Eli Lilly & Co. No. 02-CV-02211 (U.S.D.C.).
Plaintiffs Celia Roing, Diane Mullen and Elaine Philbrick claim that Eli Lilly, the drug's manufacturer, sold a defective product, failed to warn consumers of the dangers of the drug, over promoted the product and misled the FDA regarding the drug's efficacy, the complaint states.
Each of the plaintiffs was born prior to 1971 and …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach